Analysis

What Attys Need To Know About Trump’s Opioid Policies

Law360, New York (August 9, 2017, 7:12 PM EDT) -- The Trump administration’s first six months have witnessed a flurry of activity targeting the nation’s tenacious opioid epidemic, highlighting legal risks for any business that handles narcotic painkillers.

The activity has spanned much of the executive branch, including the White House, the U.S. Department of Justice and the U.S. Food and Drug Administration. Some of the moves have real promise, while others appear largely symbolic or even counterproductive, experts say.

Here’s what attorneys need to know going forward:

DOJ Casts Wide Net for Opioid Violations...
To view the full article, register now.